PetIQ, Inc. (PETQ)

USD 30.98

(-0.03%)

Total Assets Summary of PetIQ, Inc.

  • PetIQ, Inc.'s latest annual total assets in 2023 was 868.22 Million USD , up 6.02% from previous year.
  • PetIQ, Inc.'s latest quarterly total assets in 2024 Q2 was 894.39 Million USD , up 2.19% from previous quarter.
  • PetIQ, Inc. reported annual total assets of 818.89 Million USD in 2022, down -0.08% from previous year.
  • PetIQ, Inc. reported annual total assets of 819.58 Million USD in 2021, up 6.22% from previous year.
  • PetIQ, Inc. reported quarterly total assets of 875.23 Million USD for 2024 Q1, up 0.81% from previous quarter.
  • PetIQ, Inc. reported quarterly total assets of 868.22 Million USD for 2023 Q4, up 1.3% from previous quarter.

Annual Total Assets Chart of PetIQ, Inc. (2023 - 2014)

Historical Annual Total Assets of PetIQ, Inc. (2023 - 2014)

Year Total Assets Total Assets Growth
2023 868.22 Million USD 6.02%
2022 818.89 Million USD -0.08%
2021 819.58 Million USD 6.22%
2020 771.59 Million USD 14.7%
2019 672.72 Million USD 35.79%
2018 495.43 Million USD 251.76%
2017 140.84 Million USD 73.18%
2016 81.33 Million USD -11.92%
2015 92.33 Million USD 30.81%
2014 70.58 Million USD 0.0%

Peer Total Assets Comparison of PetIQ, Inc.

Name Total Assets Total Assets Difference
Journey Medical Corporation 76.84 Million USD -1029.782%
ANI Pharmaceuticals, Inc. 904.42 Million USD 4.002%
Aquestive Therapeutics, Inc. 57.41 Million USD -1412.115%
Pacira BioSciences, Inc. 1.57 Billion USD 44.853%
Sunshine Biopharma, Inc. 27.34 Million USD -3074.854%
Sunshine Biopharma, Inc. 27.34 Million USD -3074.854%
SCYNEXIS, Inc. 128.41 Million USD -576.125%
Safety Shot Inc 12.7 Million USD -6731.487%
Alpha Teknova, Inc. 128.58 Million USD -575.205%
Collegium Pharmaceutical, Inc. 1.14 Billion USD 24.06%
Bright Green Corporation 17.4 Million USD -4888.931%
Dynavax Technologies Corporation 997.09 Million USD 12.925%
Esperion Therapeutics, Inc. 205.79 Million USD -321.887%
Cosmos Health Inc. 66.29 Million USD -1209.629%
PainReform Ltd. 9.93 Million USD -8643.464%
China SXT Pharmaceuticals, Inc. 23.12 Million USD -3654.157%
Embecta Corp. 1.21 Billion USD 28.506%
Intra-Cellular Therapies, Inc. 728.29 Million USD -19.214%
Procaps Group, S.A. 460.18 Million USD -88.668%
Theratechnologies Inc. 77.76 Million USD -1016.417%
Harrow Health, Inc. 311.75 Million USD -178.496%
Sonoma Pharmaceuticals, Inc. 14.89 Million USD -5729.759%
Biofrontera Inc. 27.93 Million USD -3008.356%
DURECT Corporation 45.18 Million USD -1821.322%
Supernus Pharmaceuticals, Inc. 1.4 Billion USD 38.379%
Cronos Group Inc. 1.13 Billion USD 23.454%
OptiNose, Inc. 107.72 Million USD -705.935%
Ironwood Pharmaceuticals, Inc. 471.07 Million USD -84.308%
Kala Pharmaceuticals, Inc. 55.94 Million USD -1451.817%
RedHill Biopharma Ltd. 23.04 Million USD -3667.175%
Organogenesis Holdings Inc. 460.02 Million USD -88.735%
Guardion Health Sciences, Inc. 11.91 Million USD -7184.889%
Cumberland Pharmaceuticals Inc. 81.77 Million USD -961.712%
Radius Health, Inc. 1.71 Billion USD 49.403%
Universe Pharmaceuticals INC 53.28 Million USD -1529.338%
ProPhase Labs, Inc. 91.92 Million USD -844.473%
Phibro Animal Health Corporation 982.18 Million USD 11.603%
Procaps Group S.A. 460.18 Million USD -88.668%
Alvotech 950.09 Million USD 8.616%
TherapeuticsMD, Inc. 43.3 Million USD -1904.724%
Viatris Inc. 47.68 Billion USD 98.179%
Rockwell Medical, Inc. 52.17 Million USD -1564.129%
Aytu BioPharma, Inc. 118.09 Million USD -635.193%
SIGA Technologies, Inc. 254.83 Million USD -240.7%
Tilray Brands, Inc. 4.33 Billion USD 79.973%
Lifecore Biomedical, Inc. 273.7 Million USD -217.216%
Shineco, Inc. 84.17 Million USD -931.4%
Regencell Bioscience Holdings Limited 8.43 Million USD -10189.219%
Incannex Healthcare Limited 17.04 Million USD -4993.131%
Neurocrine Biosciences, Inc. 3.25 Billion USD 73.297%
Alimera Sciences, Inc. 153.52 Million USD -465.531%
Silver Spike Investment Corp. 88.57 Million USD -880.202%
Assertio Holdings, Inc. 286.41 Million USD -203.131%
Shuttle Pharmaceuticals Holdings, Inc. 5.95 Million USD -14487.777%
Petros Pharmaceuticals, Inc. 33.79 Million USD -2469.036%
Clever Leaves Holdings Inc. 31.24 Million USD -2678.946%
Cyclo Therapeutics, Inc. 13.24 Million USD -6453.867%
Avadel Pharmaceuticals plc 261.12 Million USD -232.493%
Hempacco Co., Inc. 18.04 Million USD -4711.961%
Talphera, Inc. 20.39 Million USD -4157.053%
Alvotech 950.09 Million USD 8.616%
Eagle Pharmaceuticals, Inc. 406.16 Million USD -113.765%
Lantheus Holdings, Inc. 1.65 Billion USD 47.417%
Currenc Group, Inc. 141.49 Million USD -513.629%
Kamada Ltd. 351.96 Million USD -146.676%
Indivior PLC 1.95 Billion USD 55.504%
Evoke Pharma, Inc. 7.06 Million USD -12182.95%
Flora Growth Corp. 23.62 Million USD -3574.875%
Cyclo Therapeutics, Inc. 13.24 Million USD -6453.867%
Evolus, Inc. 188.99 Million USD -359.384%
HUTCHMED (China) Limited 1.27 Billion USD 32.158%
Amphastar Pharmaceuticals, Inc. 1.51 Billion USD 42.612%
Akanda Corp. 8.83 Million USD -9721.569%